Exagen | 4:持股变动声明-高管 Adawi Kamal
Exagen | 4:持股变动声明-高管 ABALLI JOHN
Exagen | 4:持股变动声明-高管 Adawi Kamal
Exagen | 4:持股变动声明-高管 ABALLI JOHN
Exagen | SC 13G/A:超过5%持股股东披露文件(修正)-Laurence W. Lytton(6.8%)
Exagen | SC 13G/A:超过5%持股股东披露文件(修正)-RTW Investments, LP(8.8%),Roderick Wong, M.D.(8.8%)
Exagen | SC 13G/A:超过5%持股股东披露文件(修正)-Stonepine Capital Management, LLC(3.9%),Stonepine Capital, L.P(3.9%)等
Exagen | SC 13G/A:超过5%持股股东披露文件(修正)-James L.L. Tullis(10.7%),Tullis-Dickerson Capital Focus III, L.P.(6.5%)等
Exagen | SC 13G/A:超过5%持股股东披露文件(修正)
Exagen | 4:持股变动声明-高管 Adawi Kamal
Exagen | SC 13G/A:超过5%持股股东披露文件(修正)-Cowen Financial Products LLC(5.27%)
Exagen | SC 13G/A:超过5%持股股东披露文件(修正)-NMSIC Co-Investment Fund, L.P.(13.55%),Sun Mountain Capital Partners, L.L.C.(13.55%)
Exagen | 4:持股变动声明-高管 ABALLI JOHN
Exagen | 4:持股变动声明-高管 ABALLI JOHN
Exagen | 4:持股变动声明-董事 Kim Paul
Exagen | 3:首次持股声明-董事 Kim Paul
Exagen | 4:持股变动声明-股东 TULLIS JAMES L L
Exagen | 4:持股变动声明-高管 Nova Tina Susan
Exagen | 4:持股变动声明-董事 Stokes Frank
Exagen | 4:持股变动声明-董事 Birk Brian
暂无数据